Morphometric characteristics of the brain in patients with type 1 diabetes mellitus on diff erent modes of basic bolus insulin therapy

Objective — to study the morphometric characteristics of the brain in patients with type 1 diabetes mellitus (DM) receiving insulin therapy in diff erent modes, taking into account the variability of glycemia.

Material and methods. 120 patients with type 1 diabetes, living in Tomsk and the Tomsk Region, were examined. All patients were divided into 2 groups: group 1 — patients receiving insulin in the base-bolus regimen of multiple insulin injections (MII), group 2 — using pump insulin therapy by continuous subcutaneous infusion of insulin using a wearable dispenser (CSII). Patients took this therapy for at least 6 months before inclusion in the study. All patients underwent a general clinical examination, testing of cognitive functions using the Montreal scale (MoCA test), continuous monitoring of blood glycemia (CMG) using iPro™ 2 Professional Continuous Glucose Monitoring (Medtronic, USA), FreeStyle Libre (Abbot, USA) in for 14 days, standard magnetic resonance imaging (MRI) on a 1.5 Tesla apparatus in axial, sagittal and coronal projections using T2, TE, T1, and using programs that suppress the signal of free water. We processed the results of MRI using Free Surfer (USA) and recon-all segmentation algorithm. Statistical analysis was performed using the R-system software package.

Results. It was found that in both groups with type 1 diabetes there was a decrease in cognitive functions. It has been shown that CSII is associated with the best completion of the MoCA test. In addition, it has been reported that more frequent episodes of diabetic ketoacidosis and increased glycated hemoglobin (HbA1c) are the main causes of cognitive impairment in this group of patients. Changes in the morphometric parameters of the brain are interconnected with glycemic variability.

Conclusion. In patients with type 1 diabetes, cognitive impairment associated with acute and chronic hyperglycemia was verifi ed. Morphometric features of brain changes are more dependent on glycemic variability. CSII helps improve cognitive function.

1. IDF Diabetes Atlas, 8th edition, 2017. Available from: http://www. diabetesatlas.org/

2. Lu F.P., Lin K.P., Kuo H.K. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PloS One. 2009;4:e4144. DOI: 10.1371/journal.pone.0004144.

3. Jash K., Gondaliya P., Kirave P., Kulkarni B., Sunkaria A., Kalia K. Cognitive dysfunction: A growing link between diabetes and Alzheimer’s disease. Drug. Dev. Res. 2019;81:144--64. DOI: 10.1002/ ddr.21579.

4. Dedov I.I. Novel technologies for the treatment and prevention of diabetes mellitus and its complication. Diabetes mellitus. 2013;(3):4– 10. (in Russian) DOI: 10.14341/2072-0351-811

5. Shestakova M.V., Majorov A.Ju., Filippov Ju.I. et al. Federal clini cal guidelines for insulin pump therapy and continuous glycemic monitoring in patients with diabetes mellitus. PROJECT. Problems of endocrinology. 2015; 61(6):44–77. (in Russian)

6. Matveeva M.V., Samoilova Yu.G., Zhukova N.G., Tolmachov I.V., Brazovskiy K.S., Leiman O.P. et al. Brain neuroimaging technologies in diabetes. Russian Medical Journal. 2019; 7: 8-10. (in Russian)

7. Li W., Huang E., Gao S. Type 1 Diabetes Mellitus and Cognitive Impairments: A Systematic Review. J. Alzheimers Dis. 2017;57(1):29– 36. DOI: 10.3233/JAD-161250.

8. McAuley S.A., de Bock M.I., Sundararajan V. et al. Eff ect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol. BMJ Open. 2018;8(6):e020274. DOI: 10.1136/bmjopen-2017-020274.

9. Brunton S. Beyond glycemic control: treating the entire type 2 diabetes disorder. Postgrad. Med. 2009;121:5:68–81.

10. Slobodin T.N., Goreva A.V. Cognitive reserve: causes of impairment and defense mechanisms. International neurological journal. 2012;3:49:161–5. (in Russian)

11. Samoylova Yu.G., Matveeva M.V., Zhukova N.G., Rokank M.A. Variability of glycemia and cognitive impairment in patients with diabetes mellitus type 1. Klinicheskaya meditsina. 2018;96(8):741–5. (in Russian) DOI: 10.18821/0023-2149-2018-96-8-741-745.

12. Kappelle J.L., Heine R.H., Dekker J.M. et al. Patients with Cognitive Functioning in Elderly Persons with Type 2 Diabetes and Metabolic Syndrome: the Hoorn have more severe and frequent hypoglycemia episodes Study. Dementia and Geriatric Cognitive Disorders. 26:261–9.

13. Orr C.J., Hopman W., Yen J.L. еt al. Long-term effi cacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus. Diabetes Technol. Ther. 2015;17:49–54.

14. Klimontov V.V., Myakina N.E The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy. Diabetes mellitus. 2015;18(4):66–71. (in Russian) DOI: 10.14341/DM7181.